This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
The Michael J. Fox Foundation has launched a new arm of their Parkinson’s Progression Markers Initiative (PPMI), studying at-risk populations in Parkinson’s Disease
The PPMI has completed enrollment of its initial 600-member cohort of Parkinson’s patients and controls, and is now launching additional study cohorts to leverage the existing PPMI infrastructure and evaluate multiple potential biomarkers for Parkinson’s disease (PD).
The first of these new cohorts recent launched and will investigate risk factors for PD that may enable diagnosis before the onset of motor symptoms.
More information at the link below: